MR-guided radiofrequency ablation of hepatic malignancies at 1.5 T: initial results

J Magn Reson Imaging. 2004 Mar;19(3):342-8. doi: 10.1002/jmri.20004.

Abstract

Purpose: To assess the feasibility of magnetic resonance (MR)-guided radiofrequency ablation (RFA) of hepatic malignancies using a high-field MR scanner.

Materials and methods: A total of 10 patients with 14 primary (N = 1) or secondary (N = 13) hepatic malignancies underwent MR-guided RFA using a closed-bore 1.5 T MR scanner. Lesion diameters ranged from 2.0 cm to 4.7 cm. RFA was performed using a 200-W generator in combination with a 3.5-cm LeVeen electrode applying a standardized energy protocol.

Results: RFA was technically feasible in all patients. Necrosis diameter ranged from 2.5 cm to 6.8 cm. The mean follow-up period is 12.2 (1-18) months. In nine out of 10 patients, local tumor control was achieved. For this purpose, a second CT-guided RFA was required in two patients. In four patients, multifocal hepatic tumor progression occurred, with the treated lesion remaining tumor-free in three of these patients. Two patients showed extrahepatic tumor progression. Four patients remained tumor-free. No major complications occurred.

Conclusion: MR-guided RFA of hepatic malignancies in a closed-bore high-field MR scanner is technically feasible and safe. It can be advantageous in locations considered unfavorable for CT-guided puncture or in patients in which iodinated contrast material is contraindicated.

Publication types

  • Clinical Trial

MeSH terms

  • Aged
  • Carcinoma, Hepatocellular / surgery*
  • Catheter Ablation / methods*
  • Digestive System Neoplasms / pathology*
  • Feasibility Studies
  • Female
  • Follow-Up Studies
  • Humans
  • Liver Neoplasms / secondary
  • Liver Neoplasms / surgery*
  • Magnetic Resonance Imaging / methods*
  • Male
  • Middle Aged
  • Ovarian Neoplasms / pathology*
  • Treatment Outcome